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Abstract Outbred strains of Wistar rats contain both Introduction 
high responders to novelty (HR) and low responders to 
novelty (LR). Male HR and LR selected from the Nijme­
gen outbred strain of Wistar rats differ in their sensitivity 
to acute administration of dexamphetamine (AMPH).
Sub-chronic administration of AMPH sensitizes rats to
this agent, and this sensitization (SENS) increases when 
an intermittent, instead of continuous, regimen is used. 
Thus, the question arose whether HR and LR also differ 
in the development of sensitization to AMPH* AMPH 
(0.5 mg/kg SC) was given five times either each consec­
utive day (daily: DAY) or each alternate day (intermit­
tent: INT). Drug-induced changes in the spatio-temporal 
patterning of open field behavior were assessed for a pe­
riod of 45 min. Three sets of data were found: i) in the 
AMPH-DAY conditions: total number of excursions with 
0 stops increased in time; this SENS was far greater in 
HR than in LR; ii) the effects under AMPH-DAY condi­
tions were far greater that those under AMPH-INT con­
ditions, especially in HR; iii) under AMPH-INT condi­
tions a new phenomenon was observed: following a peri­
od in which SENS occurred, a period marked by desensi­
tization appeared which, in turn, was followed by a peri­
od with SENS being greater than the SENS seen during 
the first time; this effect was far more pronounced in HR 
than in LR. It is concluded that AMPH-INT induces 
time-dependent changes marked by consecutive periods 
of SENS and desensitization. This has far-reaching con­
sequences for hypotheses about processes giving rise to 
the development of (1) SENS to psychostimulants and, 
consequently, (2) certain aspects of addiction to these 
drugs.
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Exposure to stressors increases both the behavioral and 
the biochemical responses to subsequent stimulant ad­
ministration. For instance, a single exposure to stress en­
hances the behavioral response to dexamphetamine ad­
ministration (Antelman et al. 1980; Antelman and 
Chiodo 1983; Herman et al. 1984; Robinson et al. 1985; 
Robinson and Becker 1986; Antelman 1988). As with 
stressors, corticosteroids are also necessary for the sensi­
tization of dexamphetamine-induced locomotor activity
(Rivet et al. 1989; Cools 1991).
We have recently shown that mesolimbic otj adreno­
ceptors are critically involved in the ability of corticoste­
roids to sensitize the locomotor response to dexamphet­
amine sensitization (Cools 1991). Since it is known that 
mesolimbic a-adrenoceptors modulate the release and 
function of mesolimbic dopamine (Nurse et al. 1985; 
Cools et al. 1991), it is not surprising that both mesolim­
bic a-adrenoceptors and mesolimbic dopaminergic re­
ceptors are important for dexamphetamine-induced sen­
sitization (Gold et al. 1988; Cools 1991). In short, there 
is evidence that corticosteroids, stress, mesolimbic a-ad- 
renergic, and mesolimbic dopaminergic receptors are 
critically involved in dexamphetamine-induced sensitiza­
tion of locomotor activity.
The behavioral and neurochemical responses to drugs 
of abuse such as dexamphetamine show considerable 
variation between individual subjects (Deminière et al.
1989). For example, when low doses of psychostimulant 
drugs are used, only some rats acquire intravenous self­
administration (Piazza et al. 1989, 1990b, 1991). Previ­
ous experiments have demonstrated that drug-i indepen­
dent behavior such as locomotion in response to novelty 
or sugar intake predicts individual differences in dexam­
phetamine self-administration behavior and in locomotor 
responses to psychomotor stimulant drugs such as dex­
amphetamine and cocaine (Piazza et al. 1989, 1990 a,b; 
Hooks et al. 1991, 1992; Exner and Clark 1993; Sills and 
Vaccarino 1994). The possibility of predicting individual 
differences in the locomotor effect of dexamphetamine
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on the basis of drug-independent behavior suggests that 
differences in structure and function of the brain of the 
subjects may be an important factor in determining their 
sensitivity to drugs. However, the neurochemical mecha­
nisms determining these individual-specific differences 
in response to dexamphetamine are largely unknown.
Recently, we have studied the neurochemical and en­
docrinological differences between two fundamentally 
distinct types of rat which are normally present in unse- 
lected, outbred populations of Wistar rats: so-called Ni­
jmegen high responders to novelty (HR) and Nijmegen 
low responders to novelty (LR). These two types of rat 
are either selected from the outbred population of Nijme­
gen Wistar rats with the help of a special open field pro­
cedure (Cools et al. 1990, 1993a, b) or taken from partic­
ularly outbred lines, namely the apomorphine-suscepti- 
ble rats (APO-SUS) being identical to HR and so-called 
apomorphine-unsusceptible rats (APO-UNSUS) being 
identical to LR (for details see Cools et al. 1990, 1993a, 
b). Studies on HR or APO-SUS and LR or APO-UNSUS 
rats have revealed that the individual variation in behav­
ior of these two types of rat is the overall outcome of a 
fundamentally different structure and function of the 
brain, the neuroendocrine and the immune system (Cools 
et al. 1990, 1993a, b; Rots et al. 1995, 1996a, b). These 
two types of rat can be used to elucidate mechanisms of 
behavioral sensitization. Thus, the goal of the present 
study was to establish whether these rats show differ­
ences in the development and expression of dexamphet­
amine-induced sensitization of changes in spatio-tempo­
ral behavior.
Dexamphetamine-induced sensitization produced by 
chronic intermittent (3- or 4-day interval) treatment is 
greater than that produced by continuous treatment (Post 
1980; Antleman and Chiodo 1981; Robinson and Becker 
1986). Remarkably, there have been no studies compar­
ing daily and intermittent administration of dexamphet­
amine. Given that mesolimbic a-adrenoceptors which 
are involved in dexamphetamine sensitization can 
change their “agonistic” state into an “antagonistic” 
state, and vice versa, a situation lasting about 24 h 
(Cools et al. 1987), it was decided to use one schedule in 
which dexamphetamine was administered daily for 5 
days, and one in which the drug was given five times 
with a 24 h interval.
Materials and methods
Subjects
Thirty male Wistar rats, bred and reared in the Central Animal 
Laboratory of the University of Nijmegen, were selected with the 
help of the open field procedure described below. Animals were 
individually housed in standard plastic boxes (40 x 20 cm) and 
maintained on a 12-h day and night cycle (lights on: 0700-1900 
hours). Standard lab chow and water was continuously available. 
All aniinal experiments were performed according to internation­




A 160 x 160 cm horizontal flat glass table, 95 cm high surrounded 
by a white neutral background, served as open field. Behavior was 
recorded with a computerized automated tracking system de­
scribed by Cools et al. (1990).
Selection
Animals were placed on the open field for a period of 30 min. 
Ambulation was defined as the overall distance travelled (in 
cm/30 min); exploratory behavior was defined as the portion of the 
ambulation behavior which began after the rat was placed on the 
open field and ended when locomotor activity stopped for a period 
of 1.5 min (habituation time). Distance travelled and habituation 
time were used as criteria to select the two types of rat (Cools et 
al. 1993a). Rats which habituated in less than 480 s and locomoted 
less than 4800 cm/30 min were labeled LR, Rats which habituated 
after a period of 840 s and covered more than 6000 cm/30 min 
were labeled HR (Cools et al. 1993a). Both variables, which have 
been found to correlate fully in the Nijmegen Wistar rats (Cools et 
al. 1990), were used, since early postnatal handling that has been 
found to alter the neurochemical structure and function of the 
brain (Rots 1995) enhanced the travelling distance without chang­
ing the habituation time, indicating that travelling distance per se 
is not always a reliable criterion (unpublished data; see also Rots
1995).
Each animal was individually housed during 3 consecutive 
days prior to the start of the selection period. Animals were trans­
ported to the open field room 30 min prior to testing in order to al­
low for environmental acclimatization. All testing took place be­
tween 0900 and 1700 hours. The selection procedure produced 15 
HR [distance, mean ± SEM (cm/30 min): 8020 ± 333; habituation 
time, mean ± SEM (min): 21 ± 0.99] and 15 LR [distance, 
mean ± SEM (cm/30 min): 2440 ± 147; habituation time, 
mean± SEM (min): 3.5 ± 0.38], From the total number of rats test­
ed on the open field, 21 % were HR and 26% were LR; the remain­
ing 53% of the rats were not included in the experiment.
Experiment 1: sub-chronic daily administration 
of dexamphetamine in HR and LR
Sixteen rats (eight HR and eight LR), weighing between 205 and 
240 g at the start of the experiment, were randomly assigned to a 
sub-chronic daily treatment schedule of dexamphetamine. Each 
animal was individually housed for 3 days following the selection 
period. ¿/-Amphetamine sulphate (0.5 mg/kg SC) obtained from 
RBI (Natick, Mass., USA) was dissolved in distilled water, and 
fresh solutions were made for each test session. HR and LR were 
given daily activity tests during a period of 45 min following dex­
amphetamine injections for 5 consecutive days, Following an in­
jection of dexamphetamine, each animal was immediately placed 
in the center of the open field (described in Apparatus). Animals 
were pre-exposed to the novel open field for 30 min (during the 
selection procedure) which reduced locomotor activity at the start 
of the sensitization procedure. The animals were replaced in their 
home cages at the end of each test period.
Experiment 2: sub-chronic intermittent administration 
of dexamphetamine in HR and LR
Fourteen rats (seven HR and seven LR), weighing between 205 
and 240 g at the start of the experiment, were treated on a sub­
chronic intermittent schedule. Animals were given an equal num­
ber of treatments as in the daily condition (expt 1). Dexamphet­
amine (0.5 mg/kg SC) was administered every other day on the 
basis of a 24-h interval. The open field and method of assessment 
were the same as in expt 1.
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Behavioral analysis
The computerized automated analysis was based on the definitions 
of (a) home base, (b) excursions, and (c) stops as previously out­
lined (Eilam 1987; EJiam and Golani 1990; Golani et al. 1993). A 
“home base” was defined as the place in which the rat remains for 
the longest cumulative time and to which the number of visits is 
the highest.
An “excursion1’ or field trip was defined as the route starting 
immediately after leaving the home base and ending just before 
stopping again at the home base. Such an excursion could be ei­
ther a “round trip”, being an excursion that starts and ends at the 
same base, or a “home trip”, being an excursion between two dif­
ferent home bases (Golani et al. 1993). Once the computer pro­
gram defined the home base(s), it was able to track an excursion 
according to the above-mentioned definitions (Cools et al., sub­
mitted). The units of measurement were the number of excursions 
with zero, one and two stops, A “stop1' was defined as the inter­
ruption of an excursion, during which the rat ceased to progress 
forward and froze in place, or ceased to progress forward and per­
formed lateral and/or vertical scanning movements with any or all 
parts of its trunk while staying in place. The computer program 
traced the stop in two steps. First, the distance travelled between a 
time interval of 1 s had to be less than 15 cm. Second, the distance 
between two successive stops had to be greater than 20 cm. When 
both conditions were fulfilled, the computer program labeled such 
an interruption as a “stop”. Finally, the excursions were classified 
according to the number of stops.
Statistics
A MANOVA for repeated measures by means of the SPSS pro­
gram was used to evaluate the data. P-values were calculated with 
Averaged Tests of Significance, and the degrees of freedom were 
corrected with the Huynh-Feldt epsilon. First, a three-way AN- 
OVA for repeated measures was conducted (factor group: HR ver­
sus LR; factor procedure: daily versus intermittent; factor treat­
ment: first to fifth administration). If  significant interaction was at­
tained, a two-way ANOVA for repeated measures was conducted 
(factor group: HR versus LR; factor treatment: first to fifth admin­
istration). If significant interaction was found, a one-way ANOVA 
for repeated measures was performed (factor treatment: first to 




Figures 1A-F reveal that the occurrence of a slowly and 
steadily developing sensitization was limited to the ef­
fects of daily administration of dexamphetamine upon 
the number of excursions with zero stops (E0) in HR 
(Fig. 1A). Thus, the daily treated HR showed a far great­
er sensitization of E0 than the intermittently treated HR, 
an effect that was not seen in LR (Fig. 1A and D). This 
was confirmed by the outcome of the three-way ANOVA 
that showed a significant interaction effect for E0 [group 
(HR, versus LR) x procedure (daily vs intermit­
tent) x treatment (first to fifth administration), E0: 
F(3.92, 109,9) = 3.53; PcO.OI],
Figures 1A-F also reveal that especially the intermit­
tent administration of dexamphetamine produced oscilla­
tions in the number of excursions in HR. Thus, the sec-
sions with zero, one and two stops. A decrease was seen 
after the third treatment, followed by a slight augmenta­
tion in the number of these excursions after the fourth 
treatment which subsequently peaked again following 
the fifth treatment. This consecutive series of increases 
and decreases was especially evident for excursions with 
one stop (Ej). Indeed, the three-way ANOVA revealed 
that there was a significant interaction effect in this case 
[group x procedure x administration, E^ F(3,99, 
111.6) = 2.86; j°<0.03]; no other significant interaction 
effects were found. Given this outcome, only the number 
of Eq and E L was further analyzed with a two-way AN­
OVA to evaluate HR-LR differences in the degree of sen­
sitization per procedure (daily and intermittent, respec­
tively).
Sub-chronic daily administration 
of dexamphetamine in FIR and LR
Figure 1A shows that the daily administration of dexam­
phetamine increased the number of excursions with zero 
stops in HR to a far greater extent than it did in LR. This 
was confirmed by the outcome of two-way ANOVA that 
revealed a significant interaction [group (HR versus 
LR) x treatment (first to fifth administration), E0: F(3.10, 
43.39 = 5.36; P<0.003]. This figure also shows that the 
daily administration of dexamphetamine resulted in a 
steadily increasing number of excursions with zero stops 
in HR [one-way ANOVA: treatment (first to fifth admin­
istration) E0: F(2.29, 16.02) = 11.09; P<0.001]; a far
smaller, but still significant increase was seen in LR 
[treatment (first to fifth administration), E0: F{4, 
28) = 5.04; P<0.003].
Figure IB shows that the daily administration of dex­
amphetamine also affected the number of excursions 
with one stop in HR and LR, but there was no significant 
interaction [two-way ANOVA: group (FIR versus 
LR) x treatment (first to fifth administration): NS], indi­
cating that HR and LR did not differ in this respect; 
moreover, the factor treatment (first to fifth administra­
tion) was not significant, indicating that none of the rats 
developed sensitization in this case. The same holds true 
for the effects of daily administration of dexamphet­
amine upon the number of excursions with two stops
(Fig. 1C).
Sub-chronic intermittent administration 
of dexamphetamine in HR and LR
Figure 1D-F show that the intermittent administration of 
dexamphetamine differentially affected HR and LR. 
Two-way ANOVA revealed that this difference was only 
significant for the number of excursions with one stop 
[group (HR versus LR) x treatment (first to fifth admin­
istration), E,: F(3.57, 49.94) = 3.99; P<0.009]. Fig­
ure IE clearly shows that the intermittent administration 
ond treatment produced a peak in the number of excur- of dexamphetamine produced a consecutive series of in-
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Daily Amphetamine Administration (0.5 mg/kg) Intermittent Amphetamine Administration (0.5mg/kg)
Fig 1 À-C Sub-chronic effects of daily administration of 0.5 
mg/kg dexamphetamine on number of excursions with zero, one, 
and two stops, respectively, in Nijmegen high (HR) and low (LR) 
responders on test days 1 through 5. The vertical bars represent 
ihe standard error of the mean. D-F Sub-chronic effects of inter­
mittent administration of 0.5 mg/kg dexamphetamine of number of 
excursions with zero, one, and two stops, respectively, in Nijme­
gen high (HR) and low (LR) responders on test days 1 through 9. 
The vertical bars represent the standard error of the mean
creases and decreases in the number of excursions in HR 
that differed from that seen in LR. A subsequent one­
way ANOVA per group revealed that this effect was sig­
nificant in FIR (first to fifth administration: jF(3.80, 
26.57) = 4.23; PcO.Ol), but not in LR.
Discussion
The goals of this study were to establish whether or not 
Nijmegen HR and LR differ in their behavioral response
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to daily versus intermittent administration of dexamphet­
amine and whether group-specific differences in the de­
velopment of sensitization to dexamphetamine exist be­
tween the groups. Given that drug-induced changes in 
motor activity, as measured in standard locomotor boxes, 
were found to be insufficient in revealing major differ­
ences between both groups (Gingras and Cools 1996), 
we subsequently used a more subtle behavioral analysis 
allowing detailed examination of drug-induced changes 
in the spatio-temporal programming of behavior. Using 
this analysis, we recently found that HR are far more 
susceptible to the behavioral effects of acute administra­
tion of dexamphetamine than LR (Cools et al. 1997).
The present study, in which the rats’ progression was 
analyzed in terms of changes in the sequence of excur­
sions and stops, provides direct evidence that the HR are 
far more susceptible to the development of sensitization 
to the behavioral effects of dexamphetamine than LR. 
Moreover, a new phenomenon was observed when the 
dexamphetamine-daily and dexamphetamine-intermittent 
conditions were compared. These findings are discussed 
below.
In the first experiment, the slowly and steadily devel­
oping sensitization to dexamphetamine was only seen 
when the number of excursions with zero stops was tak­
en as dependent variable (Fig. 1A): this effect was far 
greater in HR than in LR. There was no sensitization of 
the number of excursions with one and two stops in ei­
ther HR or LR (Fig. IB, C). Thus, the effects of dexam­
phetamine vary across the dependent variables, viz. a 
finding that underlines our previous conclusion in this 
respect (Gingras and Cools 1996). In general, the greater 
sensitization seen in the ITR can partly be explained as 
follows. As mentioned in the Introduction, dexamphet­
amine is interchangeable with stress and corticosteroids 
that influence mesolimbic a-adrenoceptors. The meso- 
limbic adrenoceptors modulate the release of mesolimbic 
dopamine that, in turn, directs the sensitization of loco­
motor activity. HR show a significantly greater increase 
in corticosteroids in response to environmental or phar­
macological challenges than LR; HR also show a larger 
behavioral response to stress than LR (Rots et al. 1995, 
1996a, b). These findings together may explain the 
stronger and progressive developing sensitization of dex­
amphetamine-induced locomotor activity in HR. Our da­
ta appear to be at variance with those of Hooks et al. 
(1991, 1992), who have reported that the degree of sensi­
tization to dexamphetamine does not differ between their 
HR and LR. However, both the procedure used to select 
HR and LR and the treatment protocols differ in all re­
spects between the present study and those of Hooks and 
colleagues. Because of these differences, the outcome of 
the present study cannot be compared with those of the 
studies of Hooks and colleagues.
Apart from the overall difference in sensitization to 
dexamphetamine between HR and LR, the present data 
revealed a new phenomenon. The intermittent dexam­
phetamine treatment led to a sequence of increases and 
decreases in the number of excursions with one stop
(Fig. IE). This alternating pattern of sensitization and 
desensitization probably explains why there was no sig­
nificant difference in the number of excursions with one 
stop between the first and last injection. In contrast, daily 
dexamphetamine treated rats showed a steadily and 
slowly developing sensitization when the number of ex­
cursions with zero stops was analyzed. These two sets of 
data strongly suggest that excursions with one stop and 
excursions with zero stops are mediated by two different 
neurochemical mechanisms.
Sensitization, as seen in the daily treated rats (excur­
sions with zero stops), involves progressive increases in 
behavioral responsiveness. Until now, studies on brain 
mechanisms of sensitization have focused almost exclu­
sively on dopaminergic systems (Robinson and Becker 
1986; Kalivas and Stewart 1991). Indeed, it has been 
shown that the mesolimbic dopaminergic system is nec­
essary for a slowly developing dexamphetamine-induced 
sensitization (Robinson et al. 1988; Perugini and Vezina 
1994; for reviews see Kalivas and Stewart 1991; Robin­
son and Becker 1996). It is therefore likely that the sen­
sitization seen in the number of excursions with zero 
stops is at- least partly due to the effects of dexamphet­
amine on mesolimbic dopaminergic neurons.
The sensitization and desensitization seen in the num­
ber of excursions with one stop can be at least partly ex­
plained by a noradrenergic homeostasis process that oc­
curs at the level of receptor sites in the nucleus accumb- 
ens. First, it is known that noradrenergic receptors adapt 
their sensitivity inversely related to the level of stimula­
tion by noradrenaline (Reisine 1981). That is, an in­
creased level of noradrenaline release causes postsynap- 
tic binding sites to be sensitive to antagonists (or to be in 
an antagonistic state) but insensitive to agonists, whereas 
a decreased level of noradrenaline release causes post- 
synaptic binding sites to be sensitive to agonists (or to be 
in an agonistic state) but insensitive to antagonists (for 
references see Cools et al. 1987). Second, it has been 
shown that a single injection of phenylephrine into the 
nucleus accumbens changes the noradrenergic receptor 
“state” for a period of about 24 h (Cools et al. 1987). 
Since dexamphetamine is known to release, among oth­
ers, noradrenaline, it can be expected that dexamphet­
amine can influence the state of mesolimbic a-adreno- 
ceptors as well Indeed, we have recently collected evi­
dence that administration of dexamphetamine into the 
nucleus accumbens can reverse the “state” of mesolimbic 
a-adrenoceptors (Ellenbroek and Cools 1993). Third, 
unchallenged HR have mesolimbic a-adrenoceptors in 
the “agonist” state, whereas unchallenged LR have me­
solimbic a-adrenoceptors in the “antagonistic” state (El­
lenbroek and Cools 1993; Roozendaal and Cools 1994). 
These findings together imply that the mesolimbic a- 
adrenoceptors of HR are not only more sensitive to dex­
amphetamine-induced release of mesolimbic noradrena­
line, but also more susceptible to noradrenaline-depen­
dent changes in the “state” of the mesolimbic a-adreno­
ceptors than do LR. It is therefore postulated that the pat­
tern of sensitization and desensitization of the excursions
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with one stop, viz. a phenomenon that was clearly pres­
ent in HR, is primarily due to the effects of dexamphet­
amine on mesolimbic a-adrenoceptors.
As mentioned, the successive periods of sensitization 
and desensitization seen during intermittent administra­
tion of dexamphetamine is a new phenomenon. However, 
a comparable phenomenon has been described for co­
caine that is known to produce oscillations in the magni­
tude or direction of the organism’s responsiveness to suc­
cessive administrations of cocaine (Antelman et al,
1995). According to Antelman and colleagues (1995), 
this capacity of cocaine is due to its stressful aspect rath­
er than to its specific pharmacological properties. Given 
the concept of the interchangeability of stressors and 
psychostimulants such as dexamphetamine and the role 
of noradrenaline in this interchangeability (Antelman et 
aL 1980, 1983, 1995), the present study shows that An- 
telman’s concept about cocaine and its oscillations can 
be generalized to other psychostimulants as well.
In sum, the present study shows that the development 
and expression of sensitization of the behavioral re­
sponse to dexamphetamine is not only greater in HR 
than in LR, but also different between both groups. As 
discussed above, available knowledge about the group-
specific differences in the structure and function of the 
brain and the body of these two types of rat provides a 
firm foundation for formulating new hypotheses about 
mechanisms giving rise to the phenomenon of sensitiza­
tion of responses to psychostimulants such as dexam­
phetamine. Further research is required to provide direct 
evidence in favor of these hypotheses.
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